LeadIQ logo
Learn more at LeadIQ.com

Insights

Biopharmaceutical Innovation Idorsia Pharmaceuticals is a leading biopharmaceutical company focusing on innovative small molecule development, presenting a sales opportunity for healthcare facilities seeking cutting-edge treatments.

Strategic Partnerships Boost Financing Strategic collaborations like the $350M funding from Viatris provide Idorsia with financial stability, creating an opportunity for financial institutions or investors interested in partnering with a growing pharmaceutical player.

Leadership Transition Impact The upcoming CEO transition with André Muller taking over offers a potential sales opportunity for consultancy firms specializing in executive onboarding services or leadership development programs.

Award-Winning Treatments Idorsia's award-winning novel treatments like the chronic insomnia therapy present sales opportunities for pharmacies and healthcare providers looking to expand their offerings with cutting-edge medications.

Technology Adoption Drive Idorsia's tech stack with tools like SAP, Cloudflare, and Adobe Creative Suite indicates a tech-savvy approach, creating opportunities for technology vendors to offer advanced solutions for streamlined operations and research processes.

Similar companies to Idorsia Pharmaceuticals Ltd

Idorsia Pharmaceuticals Ltd Tech Stack

Idorsia Pharmaceuticals Ltd uses 8 technology products and services including Cloudflare, Osano, SAP, and more. Explore Idorsia Pharmaceuticals Ltd's tech stack below.

  • Cloudflare
    Content Management System
  • Osano
    Cookie Compliance
  • SAP
    Customer Relationship Management
  • Microsoft Excel
    Editors
  • SAP Sales and Distribution
    Enterprise Resource Planning
  • Ruby
    Programming Languages
  • Coupa
    Travel And Expense Management
  • Adobe Creative Suite
    Visualisation Software

Media & News

Idorsia Pharmaceuticals Ltd's Email Address Formats

Idorsia Pharmaceuticals Ltd uses at least 1 format(s):
Idorsia Pharmaceuticals Ltd Email FormatsExamplePercentage
First.Last@idorsia.comJohn.Doe@idorsia.com
91%
Last.First@idorsia.comDoe.John@idorsia.com
4%
FirstLast@idorsia.comJohnDoe@idorsia.com
2%
LastFirst@idorsia.comDoeJohn@idorsia.com
3%

Frequently Asked Questions

Where is Idorsia Pharmaceuticals Ltd's headquarters located?

Minus sign iconPlus sign icon
Idorsia Pharmaceuticals Ltd's main headquarters is located at Hegenheimermattweg 91 Allschwil, 4123 CH. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Idorsia Pharmaceuticals Ltd's official website and social media links?

Minus sign iconPlus sign icon
Idorsia Pharmaceuticals Ltd's official website is idorsia.com and has social profiles on LinkedIn.

How much revenue does Idorsia Pharmaceuticals Ltd generate?

Minus sign iconPlus sign icon
As of September 2024, Idorsia Pharmaceuticals Ltd's annual revenue reached $750M.

What is Idorsia Pharmaceuticals Ltd's NAICS code?

Minus sign iconPlus sign icon
Idorsia Pharmaceuticals Ltd's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Idorsia Pharmaceuticals Ltd have currently?

Minus sign iconPlus sign icon
As of September 2024, Idorsia Pharmaceuticals Ltd has approximately 1K employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: A. M.Chief Executive Officer: J. C.Vice President Head Of Global Supply Chain: O. K.. Explore Idorsia Pharmaceuticals Ltd's employee directory with LeadIQ.

What industry does Idorsia Pharmaceuticals Ltd belong to?

Minus sign iconPlus sign icon
Idorsia Pharmaceuticals Ltd operates in the Pharmaceutical Manufacturing industry.

What technology does Idorsia Pharmaceuticals Ltd use?

Minus sign iconPlus sign icon
Idorsia Pharmaceuticals Ltd's tech stack includes CloudflareOsanoSAPMicrosoft ExcelSAP Sales and DistributionRubyCoupaAdobe Creative Suite.

What is Idorsia Pharmaceuticals Ltd's email format?

Minus sign iconPlus sign icon
Idorsia Pharmaceuticals Ltd's email format typically follows the pattern of . Find more Idorsia Pharmaceuticals Ltd email formats with LeadIQ.

How much funding has Idorsia Pharmaceuticals Ltd raised to date?

Minus sign iconPlus sign icon
As of September 2024, Idorsia Pharmaceuticals Ltd has raised $84M in funding. The last funding round occurred on Jun 20, 2023 for $84M.

When was Idorsia Pharmaceuticals Ltd founded?

Minus sign iconPlus sign icon
Idorsia Pharmaceuticals Ltd was founded in 2017.
Idorsia Pharmaceuticals Ltd

Idorsia Pharmaceuticals Ltd

Pharmaceutical ManufacturingAllschwil, Switzerland1001-5000 Employees

The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients.

We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options.

In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core.

Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.


See our LinkedIn community guidelines:  https://www.idorsia.com/documents/com/policies-charters/idorsia-linkedin-community-guidelines.pdf
Idorsia privacy policy: https://www.idorsia.com/system/legal-statements/privacy-policy

Section iconCompany Overview

Headquarters
Hegenheimermattweg 91 Allschwil, 4123 CH
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2017
Employees
1001-5000

Section iconFunding & Financials

  • $84M

    Idorsia Pharmaceuticals Ltd has raised a total of $84M of funding over 7 rounds. Their latest funding round was raised on Jun 20, 2023 in the amount of $84M.

  • $100M$1B

    Idorsia Pharmaceuticals Ltd's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $84M

    Idorsia Pharmaceuticals Ltd has raised a total of $84M of funding over 7 rounds. Their latest funding round was raised on Jun 20, 2023 in the amount of $84M.

  • $100M$1B

    Idorsia Pharmaceuticals Ltd's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.